K. Tyler McCullough

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Preclinical studies in support of phase I/II clinical trials to treat GUCY2D-associated Leber congenital amaurosis”.

Preclinical studies in support of phase I/II clinical trials to treat GUCY2D-associated Leber congenital amaurosis

Molecular Therapy — Methods & Clinical Development(2022)10.1016/j.omtm.2022.12.007

N/A

0DataRank · unranked

7 citations

Catherine R. O’Riordan, James Morris, Michael Lukason, David M. Compton, Rena Baek +7 more

Development of an AAV-CRISPR-Cas9-based treatment for dominant cone-rod dystrophy 6

Molecular Therapy — Methods & Clinical Development(2023)10.1016/j.omtm.2023.05.020

N/A

0DataRank · unranked

8 citations

Kaitlyn R. Calabro, K. Tyler McCullough, Sean M. Crosson, Alejandro de la Cova, Diego Fajardo +3 more

Deletion of Exon 51 in a Humanized Duchenne Muscular Dystrophy Mouse Model Abolishes Ventricular Arrhythmia Predisposition

Circulation Genomic and Precision Medicine(2025)10.1161/circgen.124.004867

N/A

0DataRank · unranked

1 citations

Madeleine J. Sitton, Joel D. Bohning, Adrian Pickar‐Oliver, K. Tyler McCullough, Mary E. Moya‐Mendez +7 more